StemBANCC receives research funding from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115439, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. This website reflects only the author's views neither IMI JU nor EFPIA nor the European Commission are liable for any use that may be made of the information contained therein.